Study of Transcranial Direct Current Stimulation to Treat Epilepsy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorMayo Clinic
About this trial
The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.
Eligibility criteria
Qualifiers
Clinical diagnosis of generalized onset or focal epilepsy or sleep-related epileptic encephalopathy.
Estimated to have at least 2 countable seizures per month or spike-wave index ≥50%.
Has not had control with at least 2 anti-seizure medicines.
Able to maintain a constant medication for duration of the study (rescue meds allowed).
Disqualifiers
A disease likely to progress over course of the study.
Psychogenic non-epileptic seizures.
Suicide attempt or psychiatric hospitalization past 2 years.
A skin condition interfering with scalp electrodes or allergy to silver.
Trial design
Treatments tested in this trial
- ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)
- ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
1Mayo Clinic Minnesota55905, RochesterMinnesota, United States
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Source ClinicalTrials.gov